Trial Profile
Phase II trial of extended-dosing temozolomide in patients with melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 08 Feb 2008 New trial record.